WNT/beta-catenin signalling interrupts a senescence-induction cascade in human mesenchymal stem cells that restricts...

Area of Science:

• Cellular senescence
• Inflammation
• Regenerative medicine

Background:

• Senescence, an irreversible cell cycle arrest, causes inflammation via the senescence-associated secretory phenotype (SASP).
• Senescence and SASP contribute to aging, cancer, and degenerative diseases, hindering adult cell expansion in vitro.
• Paracrine signals are key senescence inducers, but their regulation and counteraction are poorly understood, limiting therapeutic potential.

Purpose of the Study:

• To investigate how WNT3A signaling counteracts paracrine senescence induction.
• To understand the mechanisms by which WNT3A inhibits senescence-associated inflammation.
• To explore therapeutic strategies for improving adult cell expansion and managing senescence-related diseases.

Main Methods:

• Utilized cultured human adult mesenchymal stem cells (MSCs).
• Analyzed the effects of WNT3A on paracrine senescence induction.
• Investigated the role of NF-κB and interleukin-6 signaling pathways in mediating paracrine senescence.

Main Results:

• WNT3A was found to counteract paracrine senescence induction in MSCs.
• A feed-forward cascade of senescence was observed, where senescent cells induce neighboring healthy cells into senescence.
• WNT3A interrupted this cascade by repressing senescence-inducing cytokines, and inhibiting NF-κB or IL-6 reduced paracrine senescence.

Conclusions:

• WNT3A signaling antagonizes paracrine senescence and associated inflammation.
• Interference with NF-κB or IL-6 signaling can reduce paracrine senescence and enhance MSC expansion.
• Findings provide insights into WNT's role in cellular aging and offer potential for cell-based therapies and disease management.